TY  - JOUR

T1  - Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk: a post hoc analysis of the first year of the frame study

JO  - Osteoporosis International

UR  - https://eprints.whiterose.ac.uk/171284/

PY  - 2021/02/03

AU  - McCloskey EV

AU  - Johansson H

AU  - Harvey NC

AU  - Lorentzon M

AU  - Shi Y

AU  - Kanis JA

ED  - 

DO  - DOI: 10.1007/s00198-020-05815-0

PB  - Springer Science and Business Media LLC

Y2  - 2024/12/22

ER  -